Jennison Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-210,186
Closed -$25.9M 612
2023
Q4
$25.9M Sell
210,186
-260,413
-55% -$32M 0.02% 302
2023
Q3
$60.9M Buy
470,599
+14,581
+3% +$1.89M 0.05% 155
2023
Q2
$56.5M Buy
456,018
+4,753
+1% +$589K 0.05% 175
2023
Q1
$66M Sell
451,265
-10,848
-2% -$1.59M 0.06% 151
2022
Q4
$73.6M Buy
462,113
+16,352
+4% +$2.61M 0.07% 140
2022
Q3
$59.4M Buy
445,761
+136,361
+44% +$18.2M 0.06% 156
2022
Q2
$48.3M Buy
309,400
+175,916
+132% +$27.4M 0.05% 174
2022
Q1
$20.8M Buy
133,484
+26,253
+24% +$4.09M 0.02% 347
2021
Q4
$13.7M Buy
107,231
+2,041
+2% +$260K 0.01% 418
2021
Q3
$13.7M Sell
105,190
-240,716
-70% -$31.3M 0.01% 415
2021
Q2
$61.4M Buy
345,906
+107,834
+45% +$19.2M 0.04% 186
2021
Q1
$39.1M Buy
238,072
+37,105
+18% +$6.1M 0.03% 252
2020
Q4
$33.2M Buy
+200,967
New +$33.2M 0.02% 278
2020
Q1
Sell
-4,176
Closed -$623K 661
2019
Q4
$623K Buy
+4,176
New +$623K ﹤0.01% 571
2019
Q1
Sell
-4,245
Closed -$526K 665
2018
Q4
$526K Buy
+4,245
New +$526K ﹤0.01% 604
2016
Q4
Sell
-56,937
Closed -$6.92M 812
2016
Q3
$6.92M Sell
56,937
-549,083
-91% -$66.7M 0.01% 490
2016
Q2
$85.6M Sell
606,020
-54,058
-8% -$7.64M 0.09% 194
2016
Q1
$86.2M Sell
660,078
-3,468
-0.5% -$453K 0.09% 190
2015
Q4
$93.3M Sell
663,546
-109,117
-14% -$15.3M 0.09% 181
2015
Q3
$103M Sell
772,663
-3,697
-0.5% -$491K 0.11% 173
2015
Q2
$137M Sell
776,360
-78,988
-9% -$13.9M 0.13% 149
2015
Q1
$148M Sell
855,348
-87,825
-9% -$15.2M 0.14% 142
2014
Q4
$154M Buy
943,173
+119,817
+15% +$19.6M 0.14% 133
2014
Q3
$132M Sell
823,356
-324,740
-28% -$52.1M 0.12% 155
2014
Q2
$169M Buy
1,148,096
+171,883
+18% +$25.3M 0.16% 132
2014
Q1
$135M Buy
+976,213
New +$135M 0.13% 154